Have an account?
Log in to check out faster.
Loading...
May, 2024
June, 2024
Learn why you should start your probiotics journey with Bio-K+
Our scientifically proven formulas are designed to support your unique health journey
The oral-gut axis describes the bidirectional connection between the oral microbiome and the gut microbiome. This page reviews how oral bacteria affect the gut, how gut health affects oral health, and what this oral-gut connection means for systemic health and microbiome science.
The oral-gut axis describes the bidirectional physical and immunological connection between the oral and gut microbiomes. The two sites are distinct in composition and function but physically continuous: everything that enters the digestive tract passes through the mouth first. Kunath et al. (Nature Reviews Microbiology, 2024, cited 235) describe it as one of the most significant emerging areas in microbiome science, covering direct microbial translocation, immune-mediated signaling, and metabolic crosstalk.
Adults swallow approximately 1.5 litres of saliva daily, creating a continuous flow of oral microorganisms into the gastrointestinal tract. Most are neutralized by stomach acid; when the oral microbiome is dysbiotic, certain species survive and establish in the intestine. Kitamoto et al. (PMC, 2020, cited 540) demonstrated that oral pathogens including Fusobacterium nucleatum have been detected in gut microbiome samples, with estimates suggesting up to 45% of gut bacteria may trace oral origin.
Beyond bacterial translocation, the oral-gut axis operates through immune signaling: chronic oral inflammation from periodontal disease generates systemic inflammatory signals that influence gut mucosal immune function. Li et al. described the oral-gut axis as a key pathway through which oral microbiota modulate systemic immunity — cytokines activated against oral pathogens can circulate and affect the gut. Periodontal treatment has been associated with downstream changes in gut inflammatory markers.
The oral-gut relationship is genuinely bidirectional. Park et al. (PMC, 2021, cited 277) identify gut-to-oral transmission as a distinct pathway: gut dysbiosis can alter salivary immunoglobulin A production and the oral mucosal immune environment. Individuals with inflammatory bowel disease often show altered oral microbiome profiles, and correcting gut dysbiosis in animal models has been associated with oral microbiome improvement. Oral and gut health are components of the same integrated microbiome system.
The literature links the oral-gut axis to systemic disease. Peng et al. (Nature, 2022, cited 697) reviewed associations between oral dysbiosis and cardiovascular disease, rheumatoid arthritis, colorectal cancer, and Alzheimer's disease. Xu et al. (Nature, 2025, cited 66) identified mechanisms by which oral bacteria contribute to cardiometabolic disruption via the gut. Kunath et al. (2024) summarized: oral and gut microbiomes are components of an integrated microbiota whose collective balance matters for systemic health.
The oral-gut axis frames the gut microbiome as the continuous downstream recipient of oral microbial input daily. Healthy gut bacteria resist colonization by ectopic oral species more effectively than a dysbiotic gut can. Dietary disruptions, antibiotic use, stress, and travel can reduce gut microbiome resilience. Gut-targeted probiotics contribute to the diversity and density of the gut microbial community, contributing to the resilient gut the oral-gut axis research identifies as relevant to integrated microbiome health.
Bio-K+'s formula — Lacticaseibacillus casei LBC80R®, Lacticaseibacillus rhamnosus CLR2®, and Lactobacillus acidophilus CL1285® — has been the subject of 16 published clinical trials across 45+ peer-reviewed publications. These strains help support gastrointestinal health and contribute to a healthy digestive and flora health; CFU potency is guaranteed until the best before date, not only at manufacture. More than 30 years of microbiome research at Bio-K+'s Laval, Quebec facility underpins every formulation.
The oral-gut axis describes the bidirectional connection between the oral and gut microbiomes. It operates through two primary pathways: direct translocation of oral bacteria into the gastrointestinal tract through swallowed saliva (approximately 1.5 litres daily), and indirect immune signaling whereby oral inflammation generates systemic immune responses that influence gut mucosal function. The relationship is bidirectional — gut microbiome dysbiosis can also alter oral microbiome composition. Kunath et al. (Nature Reviews Microbiology, 2024) identified this as a central focus in emerging microbiome science.
Yes. Published research confirms that oral bacteria can translocate to the gut through swallowed saliva. Kitamoto et al. (PMC, 2020, cited 540) demonstrated that oral pathogens including Fusobacterium nucleatum have been detected in gut microbiome samples of patients with gastrointestinal conditions. Studies have estimated that up to 45% of bacteria found in the gut may originate from the oral cavity. Under normal conditions, gastric acid limits oral bacterial colonization; in individuals with oral dysbiosis or compromised gut defenses, translocation may be higher.
Yes. Published research specifically describes gut-to-oral microbial transmission as a distinct pathway. Patients with inflammatory bowel disease frequently show altered oral microbiome profiles; some animal model research found that improving gut microbiome composition is associated with downstream changes in oral microbiome balance. This is one reason researchers increasingly describe oral and gut health as two components of the same integrated microbiome system.
The oral-gut axis is under active research investigation as a pathway in several systemic diseases. Peng et al. (Nature, 2022, cited 697) reviewed links between oral microbiome dysbiosis and cardiovascular disease, rheumatoid arthritis, colorectal cancer, and Alzheimer's disease. Xu et al. (Nature, 2025, cited 66) examined oral bacteria as contributors to cardiometabolic disease through gut-mediated mechanisms. Research is ongoing and causal mechanisms are not fully established for most disease associations.
The oral-gut axis research does not establish that taking a gut probiotic directly benefits oral health; no such claim is currently supported by clinical evidence. What the research establishes is that the gut microbiome receives and responds to oral bacterial input continuously, and that a stable, resilient gut microbiome is relevant to the overall balance of the integrated human microbiome.
Follow @biokplus and tag us to be mentioned